I can see the business model of the physicians and hospitals at work as they recommend tests of questionable necessity. Yet when it’s my own wife and son, it’s easy to think of a terrible outcome to avert with just one more test.
For leaders of a company looking back on 50 years of existence, Cook Group President Kem Hawkins and Chairman Steve Ferguson spend a lot of time talking about the future.
State Excise Police say just 108 of the 300,000 Indiana businesses covered by the law have been cited for violating the law, which took effect in July 2012.
Thieves broke into the Connecticut warehouse of Indianapolis-based Eli Lilly and Co. in 2010 by scaling an exterior wall and cutting a hole in the roof. They lowered themselves to the floor and disabled alarms before using a forklift to load pallets of drugs into a getaway vehicle.
The job cuts at St. Vincent Health last month were so extensive that even two of the hospital system’s C-suite executives got the ax. And one local hospital accountant predicts these cuts are just the first pass that St. Vincent—and all of its hospital peers—will have to make.
Compensation in the most common physician specialties has been growing much faster than inflation for the past five years. Now, financially squeezed hospitals are set to reverse that trend.
The $3,000 test for the first time accurately identifies the signature brain plaques of the debilitating disease.
It was not clear how many workers were losing their jobs in the Indianapolis area. However, people familiar with the cuts said the reductions were heavy in the administrative ranks, and many of those jobs are on the city’s north side.
Physicians employed by Indianapolis-area hospitals are likely to see their pay cut in the next few years unless the hospitals find new ways to be significantly more efficient.
Eli Lilly and Co. is more than 15 years late to the game in the world of diabetes drugs. And it isn’t bringing much that doctors and patients haven’t already seen. Still, that might be good enough to make a few billion a year.
The head of the state Family and Social Services Administration said Tuesday that the federal government is expected to approve an extension of the Healthy Indiana Plan, but a request to use the plan for an Indiana Medicaid expansion could take much longer.
A patent held by J&J’s Janssen Alzheimer Immunotherapy Research & Development unit isn’t valid, Judge Richard Arnold said in a ruling in London Tuesday.
Indiana consumers are set to receive rebates that are 59 percent larger this year as Obamacare continues to force health insurers to refund premiums that exceed actual medical claims by more than 20 percent.
With recent attention focused on hospital prices, WellPoint and its peers have been enjoying a nice break from their long-running status as Public Enemy No. 1 in the nation’s health care debate. They shouldn’t expect it to last.
The nation’s largest pension fund worked with the Indianapolis-based health insurer to cut medical costs 19 percent by capping the price of some surgeries, in the latest sign payers are taking a tougher line against rising hospital claims.
Lilly’s drug, if approved, may be a significant competitor to Novo Nordisk A/S’s Victoza, which generated $1.64 billion in 2012.
The federal health care overhaul is expected to exacerbate problems regarding access to care in rural Indiana communities where is there is already a shortage of doctors and other health care providers.
The founder and CEO of Diagnotes Inc. thinks his company’s mobile app can help doctors run their office from their iPhones—just as many other professionals have been doing for years.
The biotech and technology companies could see their Marion County tax abatements reduced or cancelled if officials decide they didn’t fulfill promises on new investment and hiring.
Local providers will increasingly look for help from IT firms like Indigo Biosystems Inc. and VoCare Inc. as part of a coming wave of health IT innovation that is likely to mirror the IT revolution that began 30 years ago.
